Drug Topics e-News:

Having trouble viewing this email? View in a browser.

You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.

Subscribe Now

to Drug Topics e-News

Drug Topics, Voice of the Pharmacist
Part of the Modern Medicine Network

e-News

DrugTopics.com

February 01, 2011

Drug Topics
In This Issue
Generic competition
DT Blog: No fries with that
NSAIDs cardio risks and safety
Meth on the rise
Michigan finds fault with Medicaid report
CDC’s STD guidelines
Vaccines and autism poll
Guidelines for supplement dating
Rx label standards

Updated flu guidelines

Viibryd gets approval

Natroba approved

NACDS mobile

NCPA pharmacy ownership workshops
Continuing Education

Newest: Evolving pharmacy practice in the 21st century

For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here

Meetings
Survey
Last month’s survey results:

Approximately how much of your workday is spent dealing with insurance matters?
Click Here to Vote


* 1/4 or less 30%

* up to 1/3 36%

*up to 1/2 17%

* up to 2/3 9%

* 3/4 or more 9%

This month we would like to know...

As a pharmacist, do you ever advise patients to split pills to save on costs?
* Yes

* No
Click Here to Vote

Digital Edition

Drug Topics Digital Edition View Current Edition Subscribe to the Digital Edition

Generic competition expected to be strong as many small-molecule drug brands face patent expirations

Small-molecule drugs in the United States will experience the greatest degree of brand erosion as patents of many of the most popular drugs expire during the next several years, leaving them exposed to generic competition, according to a report published by Datamonitor. Read full article.

DT Blog
Speers

A discussion generated by Drug Topics’ readers, editorial staff, and advisory board
Nicole Ebisch, PharmD, CGP

Pharmacy service: No fries with that
Read full article.

New study evaluates cardiovascular risk and safety of NSAIDs

The British Medical Journal has published a new study, which analyzed 31 randomized controlled trials comparing the cardiovascular safety of any NSAID with placebo or other NSAIDs. Read full article.

Meth activity on the rise

Despite the electronic-tracking systems for pseudoephedrine that have been implemented in several states, methamphetamine-related activity is on the rise. Read full article.

Michigan Pharmacy Association finds inaccuracies in Medicaid savings report

The Michigan Pharmacy Association criticized a new report suggesting that the state could save $146 million by moving fee-for-service Medicaid recipients to managed care programs. Read full article.

CDC’s STD guidelines add botanical treatment

The Centers for Disease Control and Prevention included a botanical treatment for genital warts in its recently revised 2010 CDC Sexually Transmitted Diseases Treatment Guidelines. Read full article.

Half of Americans polled don’t think vaccines cause autism

However, 18% are convinced that vaccines, like the MMR vaccine, can cause the disorder, and another 30% aren’t sure, according to a new Harris Interactive/HealthDay poll. Read full article.

Group unveils guideline for expiration dating of nutritional supplements

A group of regulatory, industry, and consumer groups has created a new voluntary guideline to ensure that nutritional supplement companies have the necessary data to support expiration dating on product labels. Read full article.

USP wants new Rx label standards

A new prescription drug label format is headed your way. New draft standards from the U.S. Pharmacopeial Convention could bring dramatic changes to Rx labels as early as 2012. Read full article.

ACIP updates antiviral guidelines for flu treatment

The Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention has issued revised guidelines for vaccinating patients against influenza, reported Mortality and Morbidity Report Weekly. Read full article.

FDA approves vilazodone HCl for MDD

FDA has approved vilazodone HCl tablets (Viibryd, Clinical Data) for the treatment of adults with major depressive disorder. Read full article.

FDA approves head lice treatment for children and adults

FDA approved spinosad (Natroba, ParaPRO LLC) Topical Suspension 0.9% for the treatment of head lice infestation in patients aged 4 years and older. Read full article.

NACDS launches mobile website

NACDS Mobile is the association’s new mobile website that serves as a “guide on the go” specifically designed for ease of use on any smart phone with a web browser. Read full article.

NCPA holds first of three pharmacy ownership workshops in Atlanta

NCPA is holding the first of three pharmacy ownership workshops for 2011 in Atlanta, February 4 to February 6. Read full article.

Meetings and Events

February 6-8, 2011 NACDS Regional Chain Conference
Naples, FL
Contact:
P.O. Box 34814
Alexandria, Virginia 22334-0814
703-837-4300

February 13, 2011 19th Annual WILLIAM R. BACON MEMORIAL Breakfast
6:30 a.m. - 8:45 a.m.
Palm Springs, CA
Contact:
800-333-7535; 760-325-6611

March 9-10, 2011 NACDS RxIMPACT Day on Capitol Hill
Washington, DC
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
hecker@nacds.org

March 13-15, 2011 NACDS Supply Chain & Logistics Conference
San Diego, CA
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678

March 25-28, 2011 American Pharmacists Annual Meeting
Seattle, WA
Contact:
2215 Constitution Avenue, NW
Washington, DC 20037
Phone: 1-800-237-2742 (APhA)
Fax: 202-448-8734

CEC

Connect to Us

Twitter Follow Us on Twitter
Contact Us
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here
 

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.